European legislators reach agreement on sweeping overhaul to pharma policies European legislators have reached a deal on a major rewrite of the region's pharma policies, pushing forward a framework aimed at boosting the bloc's competitiveness while strengthening supply chai | ...

EU lawmakers agree on a major rewrite of pharma rules, reshaping data and market exclusivity, speeding reviews and addressing drug shortages. Industry groups welcome faster approvals but warn incentives may fall short on competitiveness.

📰 Read more here:

#EUPharma #LifeSciences #PharmaPolicy

Which pharmaceutical companies are affected by changes to the EU’s pharmaceutical regulatory framework, and how?

www.bluefrogscientific.com/c...

#GenericPharma #EUPharma #ERA #Pharmaceuticals #GenericDrugs #RegulatoryCompliance #PharmaRegulation

Environmental Risk Assessments for Generic Drugs – Embedding environmental considerations into the pharmaceutical regulatory framework in the EU.

Learn more about the guideline changes...

www.bluefrogscientific.com/n...

#GenericPharma #ERA #EUPharma #Pharmaceuticals #GenericDrugs

What member states must do for consumers in EU pharma reform The EU pharma reform is the moment for member states to pay particular attention to what consumers need, writes Ancel.la Santos.

The European Union’s pharmaceutical legislation is undergoing its biggest reform in two decades. It is the moment for member states to pay particular attention to what consumers need. Read the blog by @ancelsantos.bsky.social 👇 #EUPharma